| mRECIST | RANO-BM | iRANO-BM |
---|
Overall response rate | 30.1% (19) | 17.5% (11) | 17.5% (11) |
Disease control rate | 65% (41) | 74.7% (47) | 81% (51) |
CR | 7.9% (5) | 3.2% (2) | 3.2% (2) |
PR | 22.2% (14) | 14.3% (9) | 14.3% (9) |
SD | 34.9% (22) | 57.1% (36) | 63.5% (40) |
PD | 34.9% (22) | 25.4% (16) | 19% (12) |
- mRECIST, modified Response Evaluation Criteria in Solid Tumors; RANO-BM, Response Assessment in Neuro-Oncology for Brain Metastases; iRANO-BM, immunotherapy Response Assessment in Neuro-Oncology adjusted for Brain Metastases; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease